Vanguard Group Inc Ocugen, Inc. Transaction History

Vanguard Group Inc

$5.37 Trillion
Q1 2025

A detailed history of Vanguard Group Inc transactions in Ocugen, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 16,683,113 shares of OCGN stock, worth $16.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

16,683,113

Previous 16,619,093 0.39%

Holding current value

$16.7 Million

Previous $13.3 Million 10.91%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 09, 2025	BUY	$0.52 - $0.9 $33,290 - $57,618	64,020 Added 0.39%	16,683,113 $11.8 Million
Q4 2024 Feb 11, 2025	SELL	$0.72 - $1.08 $237,546 - $356,320	-329,926 Reduced 1.95%	16,619,093 $13.3 Million
Q3 2024 Nov 13, 2024	BUY	$0.98 - $1.95 $1.4 Million - $2.78 Million	1,427,852 Added 9.2%	16,949,019 $16.8 Million
Q2 2024 Aug 13, 2024	BUY	$1.18 - $1.98 $4.16 Million - $6.97 Million	3,521,616 Added 29.35%	15,521,167 $24.1 Million
Q1 2024 May 10, 2024	SELL	$0.5 - $1.83 $20,183 - $73,871	-40,367 Reduced 0.34%	11,999,551 $19.7 Million
Q4 2023 Feb 14, 2024	BUY	$0.36 - $0.57 $41,171 - $65,188	114,366 Added 0.96%	12,039,918 $6.86 Million
Q3 2023 Nov 14, 2023	BUY	$0.4 - $0.62 $47,682 - $73,908	119,207 Added 1.01%	11,925,552 $4.77 Million
Q2 2023 Aug 14, 2023	SELL	$0.45 - $0.88 $543,827 - $1.06 Million	-1,208,505 Reduced 9.29%	11,806,345 $6.38 Million
Q1 2023 May 15, 2023	BUY	$0.82 - $1.33 $947,679 - $1.54 Million	1,155,707 Added 9.75%	13,014,850 $11.1 Million
Q4 2022 Feb 10, 2023	BUY	$1.11 - $1.87 $174,926 - $294,695	157,591 Added 1.35%	11,859,143 $15.4 Million
Q3 2022 Nov 14, 2022	BUY	$1.75 - $3.1 $496,564 - $879,628	283,751 Added 2.49%	11,701,552 $20.8 Million
Q2 2022 Aug 12, 2022	BUY	$1.83 - $3.45 $935,576 - $1.76 Million	511,244 Added 4.69%	11,417,801 $25.9 Million
Q1 2022 May 13, 2022	BUY	$2.34 - $4.72 $704,487 - $1.42 Million	301,063 Added 2.84%	10,906,557 $36 Million
Q4 2021 Feb 14, 2022	SELL	$4.38 - $15.67 $1.18 Million - $4.21 Million	-268,393 Reduced 2.47%	10,605,494 $48.3 Million
Q3 2021 Nov 12, 2021	BUY	$6.36 - $8.51 $3.09 Million - $4.14 Million	486,356 Added 4.68%	10,873,887 $78.1 Million
Q2 2021 Aug 13, 2021	BUY	$5.52 - $15.68 $57.3 Million - $163 Million	10,387,531 New	10,387,531 $83.4 Million

Others Institutions Holding OCGN

# of Institutions

113

Shares Held

72M

Call Options Held

200K

Put Options Held

151K

View Full List

About Ocugen, Inc.

Ticker OCGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,566,000
Market Cap $217M
Description
Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...

More about OCGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Ocugen, Inc. Transaction History